Charles River conducts contract studies in established animal models of cognitive decline associated with aging (including Alzheimer’s disease) to test the efficacy of novel therapeutics. Our aged rat and mouse models begin to exhibit cognitive, biochemical and brain metabolism deficits at approximately 20 months of age. Aged cohorts of animals are available for immediate studies.
Aged rat and mouse studies can also be combined with scopolamine-induced amnesia.